Skip to main content
. 2019 Jun 20;10:1341. doi: 10.3389/fpsyg.2019.01341

Table 2.

Means and standard deviations for outcome measures for all patients (ITT) and treatment completers by reason for seeking treatment.

Pre-treatment (ITT) Post-treatment (ITT) Follow up (COMPLETERS)
HADS-anxiety
Anxiety
Depression
Comorbid
Total sample
12.89 (3.97)
11.67 (3.47)
13.12 (3.31)
12.86 (3.67)
7.14 (3.25)
6.17 (3.10)
7.14 (2.96)
7.05 (3.11)
7.04 (5.13)
4.25 (3.53)
6.47 (3.50)
6.79 (4.46)
HADS-depression
Anxiety
Depression
Comorbid
Total sample
7.84 (3.84)
10.67 (2.57)
10.53 (3.93)
9.18 (3.99)
3.54 (3.05)
4.50 (3.34)
4.82 (3.87)
4.14 (3.45)
3.83 (4.29)
2.63 (3.66)
4.82 (4.05)
4.27 (4.19)
HADS-total
Anxiety
Depression
Comorbid
Total sample
20.73 (6.79)
22.33 (2.99)
23.65 (6.39)
22.40 (6.47)
10.68 (5.69)
10.67 (5.74)
11.96 (6.08)
11.19 (5.84)
10.87 (8.86)
6.88 (6.98)
11.29 (6.93)
11.06 (8.01)
PMC
Anxiety
Depression
Comorbid
Total sample
193.33 (69.78)
189.00 (74.87)
178.53 (68.0)
187.06 (69.35)
51.41 (59.45)
44.67 (70.02)
52.65 (61.40)
51.25 (60.79)
57.87 (68.75)
61.25 (103.43)
50.08 (57.62)
54.39 (63.77)
NMC
Anxiety
Depression
Comorbid
Total sample
193.90 (80.00)
211.67 (63.33)
218.47 (75.59)
205.33 (77.16)
40.13 (44.99)
99.58 (91.66)
64.35 (81.85)
55.45 (68.76)
61.06 (80.02)
80.63 (71.34)
70.66 (81.35)
65.35 (80.28)

Note: HADS = hospital anxiety and depression scale; CAS-1 = cognitive attentional syndrome 1; PMC = positive metacognitions; NMC = negative metacognitions; M = mean; SD = standard deviation.